- 专利标题： Compositions and Methods Related to HIV-1 Immunogens
-
申请号： US17553070申请日： 2021-12-16
-
公开(公告)号： US20220098244A1公开(公告)日： 2022-03-31
- 发明人: Leopold Kong , Ian A. Wilson , Natalia De Val , Andrew B. Ward , Dennis Burton , Linling He , Jiang Zhu
- 申请人： The Scripps Research Institute
- 申请人地址： US CA La Jolla
- 专利权人： The Scripps Research Institute
- 当前专利权人： The Scripps Research Institute
- 当前专利权人地址： US CA La Jolla
- 主分类号： C07K14/16
- IPC分类号： C07K14/16 ; A61K47/69 ; A61K39/21 ; C07K14/005
摘要：
The present invention provides HIV-1 vaccine immunogens. Some of the immunogens contain a soluble gp140-derived protein that harbors a modified N-terminus of the HR1 region in gp41. Some of the immunogens contain an HIV-1 Env-derived trimer protein that is presented on a nanoparticle platform. The invention also provides methods of using the HIV-1 vaccine immunogens for eliciting an immune response or treating HIV infections.
公开/授权文献
信息查询
IPC分类:
